Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis

OBJECTIVE: To compare the efficacy and safety of tofacitinib and baricitinib in patients with RA in a real-world setting. METHODS: A total of 242 patients with RA who were treated with tofacitinib (n = 161) or baricitinib (n = 81) were enrolled. We evaluated efficacy and safety between tofacitinib a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Arthritis Res Ther
Hoofdauteurs: Iwamoto, Naoki, Sato, Shuntaro, Kurushima, Shota, Michitsuji, Toru, Nishihata, Shinya, Okamoto, Momoko, Tsuji, Yoshika, Endo, Yushiro, Shimizu, Toshimasa, Sumiyoshi, Remi, Suzuki, Takahisa, Okada, Akitomo, Koga, Tomohiro, Kawashiri, Shin-ya, Fujikawa, Keita, Igawa, Takashi, Aramaki, Toshiyuki, Ichinose, Kunihiro, Tamai, Mami, Nakamura, Hideki, Mizokami, Akinari, Origuchi, Tomoki, Ueki, Yukitaka, Eguchi, Katsumi, Kawakami, Atsushi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2021
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8299678/
https://ncbi.nlm.nih.gov/pubmed/34301311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02582-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items